
Jackie Hunter
Jackie Hunter is the CEO of Benevolent Bio, the bioscience arm of BenevolentAI.
Jackie Hunter is the CEO of Benevolent Bio, the bioscience arm of BenevolentAI.
November 22, 2017
One technology likely to play a role in pharma’s future is AI. Artificial intelligence is already being explored as a means towards making better informed decisions, generating new hypotheses and repurposing failed drug candidates.
1 min read
November 22, 2016
Open innovation is more than just the latest pharma industry buzzword. Done right, it can help overcome funding challenges and accelerate discovery across the board.
1 min read
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
False
False